Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseCareers By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Clinical ResearchPhase 1 - Phase 4 Considering iRECIST Guidance in Evaluating Solid Tumors By Premier Research June 1, 2017 Clinical ResearchPhase 1 - Phase 4 In Treating Fibromyalgia, Goal Is Overall Benefit — Not Just Less Pain By Scott Millard May 31, 2017 Clinical ResearchPhase 1 - Phase 4 MIT’s 2017 Grand Hack Weekend, Part Two By Tom Laage May 22, 2017 Clinical ResearchPhase 1 - Phase 4 MIT’s Hacking Medicine 2017 Grand Hack Weekend By Tom Laage May 18, 2017 Clinical ResearchPhase 1 - Phase 4 Conventional Treatments for Atopic Dermatitis By Premier Research May 11, 2017 Clinical ResearchPhase 1 - Phase 4 Biologics in Psoriasis Treatment By Premier Research May 8, 2017 Previous 1 …45 46 47 48 49 … 56 Next × ALSO OF INTERESTKey Considerations When Designing a Phase 1...Nostalgia or Shell Shock? Assessing PTSD Is a...Gene Therapy 101: From the 1960s to Today